Stoke Therapeutics, Inc. · NASDAQ:STOK
Skorpios Trust reported a 13.00% stake in Stoke Therapeutics, Inc. (Schedule 13D/A)
Event Dec 23, 2024 · Filed Dec 27, 2024
Skorpios Trust reported a 13.00% stake in Stoke Therapeutics, Inc., 6,906,181 shares, with active intent on Dec 23, 2024. Filed Dec 27, 2024 (Schedule 13D/A).
- Stake
- 13.00%
- Shares
- 6,906,181
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blue Horizon Enterprise Ltd. | 5.60% | 2,967,621 |
| Ezbon International Limited | 7.40% | 3,938,560 |
| Montrago Trustees Limited | 13.00% | 6,906,181 |
| Skorpios Trust | 13.00% | 6,906,181 |